Analysis of novel disease-related genes in bronchial asthma

Yuyama, Noriko, Davies, Donna E., Akaiwa, Mina, Matsui, Keiko, Hamasaki, Yuhei, Suminami, Yoshinori, Yoshida, Ning Lu, Maeda, Miyako, Pandit, Anita, Lordan, James L., Kamogawa, Yumiko, Arima, Kazuhiko, Nagumo, Fumio, Sugimachi, Mitsuhiko, Berger, Ann, Richards, Ivan, Roberds, Steven L., Yamashita, Tetsuji, Kishi, Fumio, Kato, Hiroshi, Arai, Ken-Ichi, Ohshima, Koichi, Tadano, Jutaro, Hamasaki, Ken-Ichi, Miyatake, Shoichiro, Sugita, Yuji, Holgate, Stephen T. and Izuhara, Kenji (2002) Analysis of novel disease-related genes in bronchial asthma. Cytokine, 19 (6), 287-296. (doi:10.1006/cyto.2002.1972).

Abstract

Bronchial asthma is a complex disease characterized by airway inflammation involving interleukin (IL)-4 and IL-13. We have applied microarray analyses to human bronchial epithelial cultures to probe for genes regulated by these cytokines and have identified a subset of disease-relevant genes by comparison with cDNA libraries derived from normal and asthmatic bronchial biopsies. Squamous cell carcinoma antigen-1 (SCCA1) and SCCA2, the cysteine and serine protease inhibitors, respectively, showed the highest expression by IL-4 and IL-13, and particularly, SCCA1 was significantly increased in the asthmatic cDNA library. STAT6 was shown to be involved in expression of SCCA1 and SCCA2 in vitro. Furthermore, serum levels of SCCA were also elevated in asthmatic patients. Taken together, it was supposed that SCCA may play some role in the pathogenesis of bronchia asthma, and measuring its serum level may be relevant for diagnosing or monitoring the status of bronchial asthma. In a complex disorder such as asthma, this combination of in vitro and in vivo genomic approaches is a powerful discriminatory method enabling identification of novel disease-related genes and their mechanisms of regulation.

This record has no associated files available for download.

Contributors

Author: Donna E. Davies

Download statistics